Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression

Journal of the American Geriatrics Society

Volumn 53, Issue 6, 2005, Pages 1051-1057

  Bhogal, Sanjit K ^a   Teasell, Robert ^a   Foley, Norine ^a   Speechley, Mark ^b  

^a PARKWOOD HOSPITAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Depression; Meta analysis; Pharmacological treatment; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; HETEROCYCLIC COMPOUND; IMIPRAMINE; MIANSERIN; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; DELIRIUM; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DYSURIA; EPILEPSY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FLUTTER; HEART PALPITATION; HUMAN; MEMORY DISORDER; MENTAL IRRITATION; MOOD DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; RASH; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; STROKE; TENSION; TREATMENT OUTCOME; TREMOR; XEROSTOMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; RECURRENT DISEASE;

ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; DEPRESSION; HETEROCYCLIC COMPOUNDS; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RECURRENCE; SEROTONIN UPTAKE INHIBITORS;

EID: 23444438909     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53310.x     Document Type: Review

References (39)

1. Primeau F. Post-stroke depression: A critical review of the literature. Can J Psychiatry 1988;33:757-765.
2. Robinson RG. Post stroke mood disorders: Hosp Pract (Off Ed) 1986;21:83-89.
3. Parikh RM, Robinson RG, Lipsey JR et al. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 1990;47:785-789.
4. Aström M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993;24:976-982.
5. Kotila M, Numminen H, Waltimo O et al. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke Study. Eur J Neurol 1999;6:309-312.
6. Morris PL, Robinson RG, Andrzejewsld P et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-129.
7. Bacher Y, Korner-Bitensky N, Mayo N et al. A longitudinal study of depression among stroke patients participating in a rehabilitation program. Can J Rehabil 1990;4:27-37.
8. Morris PL, Raphael B, Robinson RG. Clinical depression is associated with impaired recovery from stroke. Med J Aust 1992;157:239-242.
9. Feibel JH, Springer CJ. Depression and failure to resume social activities after stroke. Arch Phys Med Rehabil 1982;63:276-277.
10. Robinson RG, Starr LB, Kubos KL et al. A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke 1983;14:736-741.
11. Wilson K, Mottram P, Srvanranthan A et al. Antidepressants versus placebo for the depressed elderly. (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 2003.
12. Gill D, Hatcher S. Antidepressants for depression in medical illness. (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 2003.
13. Robinson RG, Starkstein SE. Current research in affective disorders following stroke. J Neuropsychiatr Clin Neurosci 1990;2:1-14.
14. Ghika-Schmid F, Bogousslavsky J. Affective disorders following stroke. Eur Neurol 1997;38:75-81.
15. Cole MG, Elie M, McCusker J et al. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: Systematic review, J Geriatr Pyschiatr Neurol 2001;4:37-41.
16. Mulrow CD, Oxam AD, eds. Cochrane Reviewers' Handbook 2003, 4.2.0. In: The Cochrane Library Issue 3. Oxford: Update Software, 2003.
17. Hollis S, Campbell F. What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. BMJ 1999;319:670-674.
18. Mullen B. Advanced BASIC Meta-analysis. Mahwah, NJ: Lawrence Erlbaum Associates, 1989.
19. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd Ed. Hillsdale, NJ: Lawerence Earlbaum Associates, 1988.
20. Grade C, Redford B, Chrostowski J et al. Methylphenidate in early poststroke recovery: A double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79:1047-1050.
21. Trappler B, Cohen C. Using fluoxetine in 'very old' depressed nursing home residents. Am J Geriatr Psychiatry 1996;4:258-262.
22. Mayberg HS, Parikh MR, Morris PLP et al. Spontaneous remission of post-stroke depression and temporal changes in cortical S-2 serotomn receptors. J Neuropsychiatry Clin Neurosci 1991;3:80-83.
23. Dam M, Tonin P, De Boni A et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy [see comments]. Stroke 1996;27:1211-1214.
24. Reding MJ, Orto LA, Winter SW et al. Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986;43:763-765.
25. Chemerinski E, Robinson RG, Arndt S et al. The effect of remission of post-stroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis 2001;189:421-425.
26. Miyai I, Reding MJ. Effects of antidepressants on functional recovery following stroke: A double-blind study. J Neuro Rehab 1998;12:5-13.
27. Raffaele R, Rampello L, Vecchio I et al. Trazodone therapy of the post-stroke depression. Arch Gerontol Geriatr 1996;5(Suppl):217-220.
28. Marko MG. Antidepressant treatment for post-stroke depression. Neuropsychopharmacology. 1994;10:177S.
29. McCafferty G, Kilcullen P, Kligerman B et al. A psychological intervention for post-stroke depression (PSD): A controlled treatment study. J Stroke Cerebrovascular Dis 2000;9:200.
30. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after post-stroke depression. A double-blind treatment trial. Stroke 2000;31:1482-1486.
31. Lipsey JR, Robinson RG, Pearlson GD et al. Nortriptyline treatment of post-stroke depression: A double-blind study. Lancet 1984;1:297-300.
32. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram [see comments]. Stroke 1994;25:1099-1104.
33. Lauritzen L, Bendsen BB, Vilmar T et al. Post-stroke depression: Combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacol (Berl) 1994;114:119-122.
34. Palomäki H, Kaste M, Berg A et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 1999;66:490-494.
35. Wiart L, Petit H, Joseph PA et al. Fluoxetine in early post stroke depression: A double-blind placebo-controlled study. Stroke 2000;31:1829-1832.
36. Robinson RG, Schultz SK, Castillo C et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study. Am J Psychiatry 2000;157:351-359.
37. Narushima K, Kosier JT, Robinson RG. Preventing poststroke depression: A 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002;190:296-303.
38. Fruehwald S, Gatterbauer E, Rehak P et al. Early fluoxetine treatment of post-stroke depression. A three-month double-blind placebo-controlled study with an open-label long-tern follow-up. J Neurol 2003;250:347-351.
39. Rasmussen A, Lunde M, Poulsen DL et al. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003;44:216-221.